ASSISTENZA INFERMERISTICA AL PAZIENTE CON CARCINOMA DELLA PROSTATA: BISOGNI, STRATEGIE, INTERVENTI E INNOVAZIONI TERAPEUTICHE

Abstract

Il carcinoma della prostata è il tumore più diffuso tra gli uomini in Italia e nei Paesi occidentali; la sua incidenza è in aumento, ma la diagnosi precoce e le moderne tecniche di imaging permettono trattamenti efficaci e alti tassi di sopravvivenza. Poiché può presentarsi in forma asintomatica o aggressiva, è essenziale valutarne correttamente il grado per scegliere la terapia più adeguata. Le nuove cure, come gli inibitori della PARP, i radioligandi e l’immunoterapia, hanno migliorato la prognosi, rendendo tuttavia più complessa l’assistenza. In questo scenario l’infermiere svolge un ruolo fondamentale nella gestione dei sintomi, nell’educazione del paziente, nel supporto psicologico e nella promozione dell’autonomia, accompagnando con competenza l’evoluzione delle terapie per garantire una migliore qualità di vita.

Prostate carcinoma represents the most prevalent malignancy among men in Italy and other Western countries. Its incidence is steadily increasing; however, early diagnosis and the advent of advanced imaging technologies enable effective treatment and high survival rates. Given that the tumor may present as either asymptomatic or aggressive, accurate grading is crucial in determining the most appropriate therapeutic approach. Recent therapeutic innovations, including PARP inhibitors, radioligand therapy, and immunotherapy, have significantly improved patient prognosis while simultaneously increasing the complexity of clinical management. Within this evolving therapeutic landscape, the nurse assumes a pivotal role in symptom management, patient education, psychological support, and the promotion of autonomy. The ongoing development of nursing practice must therefore align with therapeutic advancements to enhance patients’ overall quality of life.Prostate carcinoma represents the most prevalent malignancy among men in Italy and other Western countries. Its incidence is steadily increasing; however, early diagnosis and the advent of advanced imaging technologies enable effective treatment and high survival rates. Given that the tumor may present as either asymptomatic or aggressive, accurate grading is crucial in determining the most appropriate therapeutic approach. Recent therapeutic innovations, including PARP inhibitors, radioligand therapy, and immunotherapy, have significantly improved patient prognosis while simultaneously increasing the complexity of clinical management. Within this evolving therapeutic landscape, the nurse assumes a pivotal role in symptom management, patient education, psychological support, and the promotion of autonomy. The ongoing development of nursing practice must therefore align with therapeutic advancements to enhance patients’ overall quality of life.